ProjectPeriodLocation(s)NPrimary outcomeStudy namePrincipal InvestigatorInstitute
CORESMA--2 locations in Germany, Nepal9000Seroprevalence of SARS-Cov-2 antibodies in Nepal and GermanyCovid-19 Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation ResearchGérard KrauseHelmholtz HZI
MuSPAD2020-06 -- 2021-055 locations in Germany60000Seroprevalence, stratified by age and over timeMultilocal and serial prevalence study for antibodies against SARS-2 coronavirus in GermanyGérard KrauseHelmholtz HZI
SARS-CoV-2 seroprevalence study2020-07 -- 2020-101 location in Germany1500Seroprevalence for SARS-CoV-2, stratified by age over timeSerial cross-sectional seroprevalence study of SARS-CoV-2 infection during and post-epidemic periods in Heidelberg and the Rhein-Neckar region, GermanyClaudia DenkingerUniversity Hospital Heidelberg, Division of Tropical Medicine
SESCiB2020-09 -- 2021-041 location in Colombia1000(1) Seroprevalence of SARS-Cov-2, (2) Asymptomatic infection ratio, (3) Associated clinical, socioeconomic, and demographic factors.Seroepidemiologic study on SARS CoV2 infection in scholar children in Bogotá, ColombiaGérard Krause and Fernando Pio De La Hoz RestrepoHelmholtz (HZI) and Universidad Nacional de Colombia
CoNAN2020-05 -- 2020-051 location in Germany626Seroprevalence for SARS-CoV-2Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR sampled and quarantined community after a COVID-19 outbreak - the CoNAN studyMathias W. Pletz and Sebastian WeisInstitute for Infectious Diseases and Infection Control, Jena University Hospital (07747 Jena, Germany)